When infrastructure holds back application performance
As a global leader in delivering expert services and support across the drug development lifecycle, Almac Group operates 18 facilities across Europe, North America, and Asia. These expert services include research and development, diagnostic services, manufacturing, formulation development, clinical trial supply services, and commercial-scale services.
A core business application is central to Almac’s global operations, affecting performance and outcomes across its workforce of more than 7,000 highly skilled employees. As the company’s operations grew, the application’s performance and ability to meet operational demands at scale became limited by the legacy infrastructure underpinning this solution.
As a service provider in a highly regulated industry, Almac needed a new hybrid infrastructure that could enable better application performance while also meeting security and compliance requirements, including those set forth by the U.S. Food and Drug Administration (FDA) in the US and the European Medicines Agency (EU).